Theressa J. Wright

1.8k total citations
18 papers, 1.3k citations indexed

About

Theressa J. Wright is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Theressa J. Wright has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Theressa J. Wright's work include Sepsis Diagnosis and Treatment (8 papers), Heart Failure Treatment and Management (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Theressa J. Wright is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Heart Failure Treatment and Management (4 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Theressa J. Wright collaborates with scholars based in United States, Belgium and United Kingdom. Theressa J. Wright's co-authors include Gordon R. Bernard, S. Betty Yan, Jeffrey D. Helterbrand, Curtis G. Wiltse, Daniel Hartman, Matthias Straub, Karl Swedberg, Jay N. Cohn, Kar Wong and E. Wesley Ely and has published in prestigious journals such as Circulation, CHEST Journal and Critical Care Medicine.

In The Last Decade

Theressa J. Wright

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Theressa J. Wright United States 10 574 422 201 197 185 18 1.3k
David P. Sundin United States 15 931 1.6× 216 0.5× 194 1.0× 290 1.5× 315 1.7× 19 1.7k
Rosalia Aloe Italy 24 207 0.4× 300 0.7× 136 0.7× 67 0.3× 62 0.3× 88 1.5k
Peter Rogiers Belgium 22 462 0.8× 132 0.3× 211 1.0× 149 0.8× 228 1.2× 43 1.6k
István Pénzes Hungary 8 710 1.2× 125 0.3× 60 0.3× 331 1.7× 286 1.5× 22 1.2k
Peter Walger Germany 16 205 0.4× 313 0.7× 72 0.4× 143 0.7× 83 0.4× 43 967
Anthony Dal Nogare United States 7 609 1.1× 125 0.3× 128 0.6× 121 0.6× 282 1.5× 7 1.4k
Thomas Pernerstorfer Austria 23 411 0.7× 395 0.9× 36 0.2× 395 2.0× 227 1.2× 58 1.7k
Sidney Tessler United States 13 586 1.0× 228 0.5× 188 0.9× 36 0.2× 255 1.4× 43 1.4k
Jeffrey S. Guy United States 15 633 1.1× 141 0.3× 130 0.6× 94 0.5× 434 2.3× 33 1.6k
Filippo Mariano Italy 24 523 0.9× 143 0.3× 51 0.3× 108 0.5× 267 1.4× 66 1.6k

Countries citing papers authored by Theressa J. Wright

Since Specialization
Citations

This map shows the geographic impact of Theressa J. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theressa J. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theressa J. Wright more than expected).

Fields of papers citing papers by Theressa J. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theressa J. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theressa J. Wright. The network helps show where Theressa J. Wright may publish in the future.

Co-authorship network of co-authors of Theressa J. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Theressa J. Wright. A scholar is included among the top collaborators of Theressa J. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theressa J. Wright. Theressa J. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Idriss, Salim F., Stuart Berger, Kimberly G. Harmon, et al.. (2017). Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium. American Heart Journal. 190. 123–131. 6 indexed citations
3.
Turner, J. Rick, Peter R. Kowey, Ignacio Rodríguez, et al.. (2016). The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. American Heart Journal. 177. 96–101. 6 indexed citations
4.
Veenhuizen, Melissa, et al.. (2006). Analysis of reports of human exposure to Micotil 300 (tilmicosin injection). Journal of the American Veterinary Medical Association. 229(11). 1737–1742. 14 indexed citations
5.
Vincent, Jean‐Louis, Gordon R. Bernard, Richard Beale, et al.. (2005). Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*. Critical Care Medicine. 33(10). 2266–2277. 219 indexed citations
6.
Bernard, Gordon R., Benjamin D. Margolis, Harvey M. Shanies, et al.. (2004). Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US). CHEST Journal. 125(6). 2206–2216. 105 indexed citations
7.
8.
Vincent, Jean‐Louis, Gordon R. Bernard, Jean-François Dhainaut, et al.. (2004). Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm, open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS. Critical Care. 8(Suppl 1). P115–P115. 3 indexed citations
9.
Cohn, Jay N., Marc A. Pfeffer, Jean L. Rouleau, et al.. (2003). Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON). European Journal of Heart Failure. 5(5). 659–667. 255 indexed citations
10.
Vincent, Jean‐Louis, Bruce Light, Theressa J. Wright, et al.. (2003). Global ENHANCE Results Indicate Organ Function Improvement With Drotrecogin Alfa (activated) in Severe Sepsis Patient. CHEST Journal. 124(4). 103S–103S. 4 indexed citations
11.
Beale, Richard, Theressa J. Wright, Kar Wong, Jean‐Louis Vincent, & Gordon R. Bernard. (2003). Safety of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis: Comparison of Global ENHANCE to PROWES. CHEST Journal. 124(4). 102S–102S. 6 indexed citations
12.
Wheeler, Arthur P., Christopher Doig, Theressa J. Wright, et al.. (2003). Baseline Characteristics and Survival of Adult Severe Sepsis Patients Treated With Drotrecogin Alfa (Activated) in a Global, Single-Arm, Open-Label Trial (ENHANCE. CHEST Journal. 124(4). 91S–91S. 13 indexed citations
13.
Swedberg, Karl, Michael R. Bristow, Jay N. Cohn, et al.. (2002). Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure. Circulation. 105(15). 1797–1803. 78 indexed citations
14.
Bernard, Gordon R., E. Wesley Ely, Theressa J. Wright, et al.. (2001). Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Critical Care Medicine. 29(11). 2051–2059. 197 indexed citations
15.
Mosca, Lori, Elizabeth Barrett‐Connor, Nanette K. Wenger, et al.. (2001). Design and methods of the Raloxifene Use for The Heart (RUTH) study. The American Journal of Cardiology. 88(4). 392–395. 129 indexed citations
16.
Yan, S. Betty, Jeffrey D. Helterbrand, Daniel Hartman, Theressa J. Wright, & Gordon R. Bernard. (2001). Low Levels of Protein C Are Associated With Poor Outcome in Severe Sepsis. CHEST Journal. 120(3). 915–922. 202 indexed citations
17.
Dickstein, Kenneth, Cord Manhenke, Torbjørn Aarsland, et al.. (2000). The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure. International Journal of Cardiology. 75(2-3). 167–176. 24 indexed citations
18.
Steinberg, Mitchell I., et al.. (1998). Cardiac Sodium Channels as Targets for New Inotropic Agents. Heart Failure Reviews. 2(3). 173–193. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Sundin Breakdown of academic impact, for papers by Rosalia Aloe Breakdown of academic impact, for papers by Peter Rogiers Breakdown of academic impact, for papers by István Pénzes Breakdown of academic impact, for papers by Peter Walger Breakdown of academic impact, for papers by Anthony Dal Nogare Breakdown of academic impact, for papers by Thomas Pernerstorfer Breakdown of academic impact, for papers by Sidney Tessler Breakdown of academic impact, for papers by Jeffrey S. Guy Breakdown of academic impact, for papers by Filippo Mariano
Rankless by CCL
2026